4
Changes in Ownership
MBX Biosciences, Inc. Filed Acc 0001193125-26-214574
President & CEO sold 607 shares at $29.54 ($17,931)
From the SEC's structured data for this filing
Trades in this filing
Hawryluk P. Kent · President & CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-05-06 | Sale : show line 1 in the form | −607 | $29.54 | $17,931 | 727,667 | D |
| Open-market sales · 607 sh · avg $29.54 · $17,931 | ||||||
Loading xslF345X06/ownership.xml…